Perrigo (PRGO) EBIT Growth (3y) (2016 - 2026)
Perrigo (PRGO) EBIT Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 29.31% |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 4.24% |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 0.90% |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 1.82% |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -74.25% |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 27.21% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 35.42% |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Perrigo | 1.91 Bn | 1.51 Bn | 313.90 Mn | -25.49% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | -25.49% |
| Mar 28, 2026 | -113.09% |
| Dec 31, 2025 | -251.74% |
| Sep 27, 2025 | 29.93% |
| Jun 28, 2025 | 104.72% |
| Mar 29, 2025 | 29.29% |
| Dec 31, 2024 | 34.73% |
| Sep 28, 2024 | -43.18% |
| Jun 29, 2024 | 40.52% |
| Mar 30, 2024 | -45.40% |
| Dec 31, 2023 | -34.16% |
| Sep 30, 2023 | -7.51% |
| Jul 1, 2023 | -3.24% |
| Apr 1, 2023 | -17.51% |
| Dec 31, 2022 | 41.58% |
| Oct 1, 2022 | -15.26% |
| Jul 2, 2022 | -28.57% |
| Apr 2, 2022 | -40.36% |
| Dec 31, 2021 | -24.26% |
| Oct 2, 2021 | 77.50% |